Taligen Acquired by Alexion

Congratulations to the team at Taligen Therapeutics, Inc. who announced yesterday that they have been acquired by Alexion Pharmaceuticals [ALXN-G].  The Taligen transaction represents the first liquidity event in Colorado Fund I.  You can read more about the transaction in Alexion’s press release.

No Comments

Leave a responce

Subscribe

Search

Categories